Podcasts about Diabetes

Neste FD vamos falar sobre a aprovação da combinação icodeca com semaglutida no tratamento de pacientes diabéticos tipo 2 no Brasil. Siga @endodirect e acesse: endodirect.com.brReferencias:Mathieu C, Giorgino F, Kim SG, et al. Once-weekly IcoSema versus once-weekly insulin icodec in type 2 diabetes management (COMBINE 1): an open-label, multicentre, treat-to-target, randomised, phase 3a trial. Lancet Diabetes Endocrinol. 2025;13(7):568-79. doi:10.1016/S2213-8587(25)00096-8Lingvay I, Benamar M, Chen L, et al. Once-weekly IcoSema versus once-weekly semaglutide in adults with type 2 diabetes: the COMBINE 2 randomised clinical trial. Diabetologia. 2025;68(4):739-51. doi:10.1007/s00125-024-06348-5Billings LK, Andreozzi F, Frederiksen M, et al. Once-weekly IcoSema versus multiple daily insulin injections in type 2 diabetes management (COMBINE 3): an open-label, multicentre, treat-to-target, non-inferiority, randomised, phase 3a trial. Lancet Diabetes Endocrinol. 2025;13(7):556-67. doi:10.1016/S2213-8587(25)00052-XJi L, Benamar M, Mohan V, et al. Once-weekly IcoSema versus once-daily insulin glargine U100 in type 2 diabetes management (COMBINE 4): an open-label, multicentre, treat-to-target, randomised, phase 3b trial. Lancet Diabetes Endocrinol. 2026;14(10):831-40. doi:10.1016/S2213-8587(26)00136-1

„Der Blutzuckerwert scheint normal zu sein. Und trotzdem kann der Stoffwechsel bereits aus dem Gleichgewicht geraten.“ Eine Insulinresistenz kann sich über Jahre entwickeln, ohne dass der klassische Nüchternblutzucker auffällig wird. Der Grund: Die Bauchspeicheldrüse produziert zunächst einfach mehr Insulin, um den Zucker weiterhin zuverlässig aus dem Blut zu bekommen. In dieser Folge der artgerecht HEALTH NERDS erklären Podcast-Host Felix Moese und Gesundheitswissenschaftler Matthias Baum, wie Insulinresistenz entsteht und welche frühen Warnzeichen darauf hindeuten können. Zunehmendes Bauchfett, Müdigkeit nach Mahlzeiten, Heißhunger, Leistungsschwankungen oder ein starkes Unterzuckerungsgefühl sind keine Diagnose, können aber Hinweise liefern. Bleibt die Insulinresistenz dauerhaft bestehen, kann sich daraus Prädiabetes und schließlich Typ-2-Diabetes entwickeln. Auch Fettleber, metabolisches Syndrom und Herz-Kreislauf-Erkrankungen stehen eng mit einem gestörten Glukose-Insulin-Stoffwechsel in Verbindung. Entscheidend ist deshalb der Blick über den Blutzucker hinaus. Nüchterninsulin und HOMA-Index können zeigen, wie viel Insulin der Körper benötigt, um einen scheinbar normalen Glukosewert aufrechtzuerhalten. Auch Triglyceride, HDL, Taillenumfang und weitere Stoffwechselparameter helfen, Veränderungen früher zu erkennen. Ein einzelner Wert reicht dafür nicht. Entscheidend ist das Gesamtbild. Und genau hier liegt die Chance: Insulinresistenz ist kein unumkehrbarer Prozess. Bewegung und Muskelarbeit, weniger dauerndes Snacken, eine angepasste Ernährung, ausreichend Schlaf und der Abbau von viszeralem Fett können die Insulinsensitivität deutlich verbessern. Wir müssen also nicht warten, bis aus einer Stoffwechselverschiebung eine Erkrankung wird. Wer die frühen Veränderungen erkennt, kann rechtzeitig gegensteuern. HEALTH NERDS. Mensch, einfach erklärt. Spare 15% auf Deine erste Bestellung auf https://artgerecht.com mit dem Code: HEALTHNERDS15 (im Warenkorb eingeben) Ein ALL EARS ON YOU Original Podcast.

407: If you are wanting to lose weight, get off medications, improve your brain health, metabolic health, reverse diabetes, and even help with your gut issues, this episode is JUST for you! Oh, and you don't need to spend any money on a special supplement, pill, or biohacking device. - Today's episode may be my favorite interview not just this year, but in all the 4 years I've had this podcast! I know that's saying a lot, but honestly, we didn't even scratch the surface of what we covered with Dr. Anthony Chaffee. You may have heard of him, but if you haven't, Dr. Anthony Chaffee is a medical doctor who earned his degree from the Royal College of Surgeons and has worked as a neurosurgical registrar and resident in Australia, while often coming back to the U.S.He is a hardcore carnivore, or "strict" carnivore, and has personally experienced major health benefits. He has also seen his own patients reverse type 1 & 2 diabetes, get off all medications, reverse dementia and Alzheimer's, improve gut issues such as Crohn's and colitis, reduce inflammation in the body, and so much more, all by removing plants and eating meat. We also discuss the corrupt food industry and the literature behind studies that say you need fiber or that carbs aren't the issue, because many may not know that the people and companies funding these studies will, more often than not, sway the outcome in their favor. Topics Discussed: → Why Dr. Chaffee Went Carnivore → Studies That Show Improvement With a Carnivore Diet → Dementia, Alzheimer's, Parkinson's Disease, IBS, Crohn's, Colitis, Weight Loss, Arthritis, Fatigue, Type 1 & 2 Diabetes → Why No Dairy? → Is Carnivore Safe for Kids? → The Corrupt Industry → Who's Really Funding These Studies? → Why Vegetables Cause Harm → Misconceptions About the Carnivore Diet → How to Do Carnivore While Your Family Doesn't As always, if you have any questions for the show please email us at digestthispod@gmail.com. And if you like this show, please share it, rate it, review it and subscribe to it on your favorite podcast app.  Sponsored By:  → Our Place | Go to https://fromourplace.com/ and use code DIGEST for 10% → Manukora | Head to ⁠https://manukora.com/DIGEST to save up to 31% plus $75 worth of free gifts with the Starter Kit, which comes with an MGO 850+ Manuka Honey jar, 5 honey travel sticks, a wooden spoon, and a guidebook! Timestamps: → 00:00:00 - Introduction  → 00:05:26 - Anthony Chaffee's Approach to Metabolic Health → 00:09:52 - Why Anthony Follows a Carnivore Diet → 00:12:20 - Hunger Signals and Nutrient Needs → 00:20:26 - Anthony's Experience Going Carnivore → 00:25:12 - Carnivore Health Benefits → 00:30:00 - Carnivore and Diabetes → 00:32:16 - Carnivore and Autoimmunity → 00:36:48 - Plant Toxins, Carnitine and B12 → 00:44:08 - Carnivore, Alzheimer's and Chronic Disease → 00:48:08 - Should Kids Eat a Carnivore Diet? → 00:54:22 - Carnivore and Childhood Development → 01:00:00 - Helping Your Family Transition to Carnivore → 01:06:48 - How Dietary Guidelines Changed → 01:09:42 - Big Sugar and Nutrition Research → 01:14:12 - Food Industry and Research Funding → 01:17:42 - Tobacco, Food and Addiction → 01:22:06 - Industry-Funded Studies → 01:27:34 - Can We Trust Nutrition Research? → 01:29:00 - Final Thoughts Further Listening: → Lose Weight, Reverse Diabetes & Reduce Joint Pain, Gut Issues + Mental Health | Dr. Shawn Baker Check Out Dr. Anthony Chaffee: → Instagram → Website → Youtube Check Out Bethany: → Bethany's Instagram: @lilsipper → YouTube → Bethany's Website → Discounts & My Favorite Products → My Digestive Support Protein Powder → Gut Reset Book  → Get my Newsletters (Friday Finds) Learn more about your ad choices. Visit megaphone.fm/adchoices

Frozen shoulder (also known as adhesive capsulitis) can cause pain, stiffness and a significant loss of shoulder range of motion. In this episode, biomechanist Katy Bowman and biologist Dr Jeannette Loram explain what's actually happening inside the shoulder capsule during frozen shoulder. They discuss the different stages of the condition — including the freezing, frozen and thawing phases — as well as its connections with inflammation, menopause and diabetes.They also explore why movement matters for shoulder health, and during recovery from frozen shoulder. To understand how movement can affect the shoulder capsule, it's important to distinguish between movement in the shoulder and movement of the shoulder. Katy and Jeannette also look at everyday habits that may limit capsule movement and share some practical daily movements for maintaining shoulder mobility. Plus, they answer a listener's question about using hand paddles when swimming.Enhanced Show Notes and Full Transcript00:00 Why we're talking about frozen shoulder02:45 Dynamic Collective sponsors05:05 What is frozen shoulder (adhesive capsulitis)?14:28 Frozen shoulder, inflammation, menopause & other risk factors24:37 The freezing, frozen & thawing stages — and treatment29:16 Movement as prevention: moving in the shoulder vs movement of the shoulder33:00 Daily prehab & rehab movements37:22 Why, in this case, pain might be the way through40:58 Everyday shoulder habits: bags, carrying & asymmetry43:13 Should you swim with hand paddles? — listener question sponsored by ScreenFit™51:00 Your shoulder movement diet: climbing & clambering, hanging & “paint the globe”Research Mentioned Millar, N. L. et al. (2022). Frozen shoulder. Nature Reviews Disease Primers, 8, 59. https://doi.org/10.1038/s41572-022-00386-2Navarro-Ledesma, S. (2025). Frozen Shoulder as a Systemic Immunometabolic Disorder: The Roles of Estrogen, Thyroid Dysfunction, Endothelial Health, Lifestyle, and Clinical Implications. Journal of Clinical Medicine, 14(20), 7315. https://doi.org/10.3390/jcm14207315Salamh, P. et al. (2025). An International Consensus on the Etiology, Risk Factors, Diagnosis and Management for Individuals with Frozen Shoulder: a Delphi study. Journal of Manual & Manipulative Therapy, 33(4), 309–320. https://doi.org/10.1080/10669817.2025.2470461Podcasts mentioned Ep 187: Diabetes and Exercise: How Exactly Muscle Movement Manages Blood SugarEp 208: Too Much Sitting, Spiky Cholesterol and Heart DiseaseConnect, Move & Learn with KatyFree Shoulder Class With Katy: How to Move In the Shoulder Joint Join Our Newsletter: Movement Colored GlassesFollow Katy on SubstackTry Katy's Virtual Studio Free for 7 days!Made Possible By Our Wonderful Sponsors:Venn Design: Beautifully upholstered ball-shaped Air Chairs and floor cushions that encourage dynamic sittingFreet Barefoot: creators of comfortable barefoot shoes built for natural movement, flexibility, and durability— use code DNA10 for 10% off.ScreenFit™: a complete online vision training program —take $200 off with code NUTRITIOUSMOVEMENTIkaria Design: The Soul Seat® offers height-adjustable, multi-position sitting—get 10% off new chairs and desks with code DNA10Movemate: Active standing boards with smoothly articulating wooden slats. Designed to keep you moving without interrupting your focus.My Happy Feet: Toe-spacing socks that gently realign toes for comfortable shoe recovery—take 20% off with code MYDNAEarth Runners:  makers of minimalist earthing sandals designed for natural foot movement and connection to the ground— use code DNA10 for 10% off. October Retreats 2026 

Send us Fan MailContrary to popular belief, you don't develop diabetes because you failed to watch what you ate. Steering clear of carbohydrates and staying thin won't prevent you from developing insulin resistance. In this episode, we explore the just world fallacy and why society is so hell bent on blaming fat people for developing a medical condition. If you're looking for a way to manage your blood sugar without the weight stigma and the lifestyle BS, check out my new book My Blood Sugar is High.Got a question for the next podcast? Let me know!Connect With MeBUY THE BOOK: Never suffer through another through another weight loss lecture from your doctor againJOIN THE NO WEIGH MOVEMENT: Get a free script when you sign upTHE WEIGHTING ROOM: Community with a neurodivergent flavour. **BOOK CLUB** exclusive to Weighting Room members. BOOK A CONSULTATION: For the ultimate transformation in your healthcare journeyEXPLORE THE MASTERCLASS LIBRARY: Become an expert in your condition and the weight inclusive ways to manage itFREE GUIDES:Evidence-based, not diet nonsenseFind me on Instagram, YouTube, and LinkedIn.

Diabetes affects millions of Americans, but understanding the basics can make a big difference. In this episode of Live Well with Southwell, Bryson Simpson, FNP-C, with Southwell Internal Medicine in Valdosta discusses Type 2 diabetes, including risk factors, prevention, treatment and management, and how family members can support loved ones living with diabetes.

Retatrutida reduce más de 18 %  el peso corporal: The Lancet  Polo se degrada a tormenta tropicalSonora mantiene operativo de auxilio tras paso de PoloMás información en nuestro podcast  #grc

In 2016, Singapore declared a War on Diabetes. This BRAVE compilation looks at what the Singapore blueprint gets right on health and public policy, and what that stability may cost in entrepreneurial drive. Dr. Sue-Anne Toh of NOVI Health explains TOFI (thin outside, fat inside), why Asians develop diabetes at lower BMI, and how insulin resistance works. Adriel Yong of Clouted lays out the efficiency paradox: when public services work this well, fewer people grow up as problem solvers, and state ownership leaves few business families to build on. Dr. Joshua Wang of VerImmune covers why cancer is detected too late, why new therapies are tested on late-stage patients first, and how diabetes went from a death sentence to a chronic disease. Watch the full episodes: Navigating the Longevity Market | Dr. Sue-Anne Toh - E718 https://www.youtube.com/watch?v=pP0L_qhSRJA  Singapore Works Too Well To Be A Great Startup Hub? | Adriel Yong - E705 https://www.youtube.com/watch?v=eOimzcac29w  Joshua Wang: Reprogramming Cancer, Biotech's Funding Shift & Why AI Will Rewrite Biology – E628 https://www.youtube.com/watch?v=roXPyXASiRk  Watch, listen or read the full insight at https://www.bravesea.com/blog/singapore-health-policy  BRAVE is Southeast Asia's leading tech podcast, hosted by Jeremy Au. Honest conversations with the region's top founders, investors, and operators on building startups in Southeast Asia. New episodes every week. Subscribe so you never miss one. Listen & Subscribe YouTube (English), YouTube (Bahasa Indonesia), Spotify (English), Spotify (Bahasa Indonesia), Spotify (Chinese), Spotify (Vietnamese), Apple Podcasts Follow BRAVE LinkedIn, X (Twitter), Instagram, TikTok, WhatsApp Follow Jeremy Au LinkedIn, X / Twitter, Instagram, TikTok, Facebook, Threads, Twitch Resources Get transcripts, startup resources & community discussions at www.bravesea.com #Singapore #Healthcare #SoutheastAsia #PublicHealth #Diabetes #WarOnDiabetes #HealthPolicy #Longevity #Biotech #Cancer #Immunotherapy #Startups #SingaporeStartups #VentureCapital #Founders #Entrepreneurship #SEAstartups #TechPodcast #BRAVEsea 00:00 Intro 01:02 Dr. Sue-Anne Toh: Singapore's War on Diabetes 01:47 TOFI: thin outside, fat inside 03:38 Insulin resistance and the pancreas "factory" 06:43 AI, manual labor and the WALL-E future 08:28 Adriel Yong: the Efficiency Paradox 10:04 Temasek, GLCs and the missing business families 11:39 Focus or numbing? HF0 and founder distraction 14:21 Why swing for a billion? 16:12 Dr. Joshua Wang: therapeutic, not preventative 18:36 Why cancer is detected too late 21:27 From death sentence to chronic disease 22:55 Outro

Can the people around us influence how well we eat? In this episode, Douglas Taren speaks with lead author Halimatou Alaofè to discuss how support from family, friends, and peers may help people with Type 2 Diabetes make and maintain healthier dietary choices.

#PAINCAST #medicina #neurocirurgiafuncionalAPRESENTADORES:Dr Alessandro Mesquita - Instagram @dr.alessandro_ortopediaedorDr Andre Meireles Borba - Instagram @dr.andreborba_neurocirurgiaoINSTAGRAM DO CANAL:@pain.castCAPTAÇÃO E TRANSMISSÃO:Carbono Studios - Instagram @Carbono.studios

O uso de agonistas de GLP-1 pode estar associado a efeitos adversos gastrointestinais severos, como vômitos persistentes, que trazem o risco de deficiência de tiamina. Neste episódio, você vai aprender como conduzir esse quadro clínico e implementar estratégias de prevenção essenciais na prática médica.Endocrinologia descomplicada para médicos e residentes.Aqui você encontra conteúdos sobre atualização médica, casos clínicos e preparação para provas de título.

I denne episoden av Helsekanalen diskuterer vertene Bjørn Tori Johansen og Kevin André Hansen Svenske de helsefordelene ved berberin og krom. Episoden utforsker hvordan disse stoffene kan påvirke blodsukkerregulering, insulinresistens, og generell helse. Gjestene deler også sine erfaringer fra klinikken og butikkene, samt forskning som støtter bruk av disse kosttilskuddene. Programmet er et must-see for alle som er interessert i naturlig helse.

Health is one of those areas you can churn through cash. It's expensive to visit your GP, but also expensive to fund. The amount taxpayers spend on health has one up 100% over the past decade. It was around 15 billion in 20216. It's now up over 30. The population has not increased by that much. Only roughly 15%. But there are always better medicines to buy. Unions to settle pay negotiations with. New equipment to buy. Hospitals to replace. It's a money pit. Every election we get the same message, which is basically, let's put more money in the pit. And both Labour and National are saying they will do this. Hell, even ACT is saying the same. But are we missing a trick by always focussing on money in and patients out? Diabetes and obesity are massive problems for the health system. As is aging, though we can't do much about that. But where is the focus in this campaign, outside of New Zealand First's policy, on the food pyramid and keeping ourselves healthy and fit? You are what eat. That's not just an old saying. It's science. To his credit, Robert F. Kennedy Jr. is pushing this in the States. Why aren't we? If we want to keep the status quo and continue funding an ambulance at the bottom off the cliff then we're going the right way about it.See omnystudio.com/listener for privacy information.

Everyone in your family has diabetes, so you figure you are going to get diabetes next. That is not actually how it works. Dr. Kien Vuu was chief of interventional radiology when he got the diagnosis himself. Diabetes, high blood pressure, about fifty pounds he didn't want, and a handful of prescriptions. He was forty. If he had stayed in the system he trained in, he says he would still be on all of it, plus more by now. He doesn't have either diagnosis anymore. What he explains in this episode is the difference between having a gene and turning it on. Every cell in your body carries the same DNA, but a heart cell and an eye cell act nothing alike, because different genes are switched on in each one. What decides which ones get switched on is everything going on around that cell. Your food. Your sleep. And a bigger one than most people expect, whether your body thinks you are safe. When your nervous system reads danger, it turns inflammation up and it turns your immune system down. That makes sense if something is actually chasing you. It is a problem if your body has been in that state for fifteen years. I did push back on him, because there is a version of this conversation that turns into blaming sick people for being sick. He answers that head on. Nobody controls every single thing, and that was never the point. The point is how much of it you do. You have been treating your family history like a verdict. You get a say in what happens. Want more practical health tips? Join my newsletter! https://freechapter.lpages.co/newsletter-opt-in/ "Fine" isn't the same as well. Stop waiting to collapse before someone listens. Build your case: https://freechapter.lpages.co/how-to-build-a-case-for-yourself/ Check us out on social media: https://www.instagram.com/drefratlamandre https://www.facebook.com/drefratlamandre https://www.tiktok.com/@drefratlamandre #functionalmedicine #drefratlamandre #medicaldisruptor #NPwithaPHD #nursepractitioner #medicalgaslighting Chapters 0:00 - Introduction 7:33 - What Is Epigenetics? 10:31 - Why Conventional Medicine Misses the Whole Body 16:51 - How Stress Switches On Inflammatory Genes 23:05 - Small Shifts for Doctors & Patients 28:02 - Is It Victim Blaming? Control What You Can Guest Links: FB: https://www.facebook.com/doctorvmd IG: https://www.instagram.com/doctorvmd YT: https://www.youtube.com/ ⁨@DoctorVMD⁩ Website:https://kienvuu.com Learn more about your ad choices. Visit megaphone.fm/adchoices

 GLP-1s + Type 1 Diabetes — what do you actually need to know? Matt sits down with Coach Lindsay, RD & CDCES living with T1D, to break down GLP-1s, insulin sensitivity, appetite, potential risks, and what people with T1D should consider before exploring them.A conversation worth watching if you've been curious about GLP-1s. Watch the full episode and keep up the fight!  - What Type 1 Diabetics Need to Know About GLP-1sGrab your ticket and join us at T1D Mastery Live!https://t1dmasterylive.com>> ENJOY!Get the Free Diabetes Training: https://diabetesinaction.comoin Us for T1D Mastery Live in San Diego: https://t1dmasterylive.comJoin The Tribe: https://thewarriorstribe.comPurchase your copy of "The Blood Sugar Freedom Formula" book TODAY!https://www.amazon.com/dp/1964811880?psc=1&smid=ATVPDKIKX0DER&ref_=chk_typ_quicklook_imgToDpGrab your free ticket to this advanced T1D training here:https://diabetesinaction.comFree T1D Support Group Here: https://diabetesinaction.com/join-group-1---------Welcome to the Pardon My Pancreas podcast!! This show is all about REAL life with type 1 diabetes, understanding fluctuations, and how to stabilize your blood sugar for good. Your host is Matt Vande Vegte is a certified personal trainer, nutritionist, and type 1 diabetic whose biggest goal in life is to help people with diabetes around the world live their lives fearlessly. Looking for an online health coaching program to help you live your best life? Go to https://www.ftfwarrior.com to learn more about his program for diabetics only that is focused on helping you reach your goals while living a happier and healthier life. Join the Tribe today!This podcast is sponsored by FTF Warrior - An online health and fitness coaching company for type 1 diabetics dedicated to helping them master their blood sugars through any activity, exercise, or meal!https://www.ftfwarrior.comFollow Matt here:Instagram: https://www.instagram.com/ftfwarrior/Facebook: https://www.facebook.com/ftfwarrior/YouTube: https://www.youtube.com/c/ftfwarrior------------------------------------------------------Disclaimer: While we share our experiences with diabetes, nothing we discuss should be taken as medical advice. Please consult your doctor or medical professional for your health and diabetes management. 

After almost 20 years living with Type 1 diabetes, I've started to see a pattern that I can't unsee.Almost every challenge I hear from clients, from listeners, from people reaching out on social media comes back to three or four specific things. And when those things click for you so many other problems start solving themselves without anyone having to try that hard.Graham and I also get into the endocrinologist relationship and what it actually should look like. Both approaches are valid — but the question underneath both of them is the same one I want everyone listening to sit with.There are 525,600 minutes in a year. Your doctor sees you for maybe sixty of them. What are you doing with the other 525,400 minutes you're not with them?

Sección semanal sobre salud bucodental. Con Iniesta Dental

In der heutigen Folge von Treffpunkt Diabetes sind wir erstmalig außerhalb des Studios unterwegs: Diesmal sind nämlich WIR zu Gast bei unseren Gesprächspartnerinnen vom Rehabilitationszentrum Alland. Wir sprechen heute über ihr Jugendturnus Programm, wo Jugendliche ihren Diabetes besser kennenlernen können, sich in einem geschützten Umfeld mit Nahrungsmitteln und Bewegung ausprobieren und auch mit dem gefährlichen Thema Alkohol in Berührung kommen können.

One-med-at-a-time sounds tidy on paper, but alcohol use disorder rarely behaves like a tidy problem. Dr. Reb Close and I sat down to discuss treating alcohol use disorder, and we've learned that many patients do better when we treat AUD the way we treat other chronic conditions: with a multimodal plan that targets more than one pathway and stays anchored to the person's real reason for drinking. We walk through how we think about combination medication strategies for alcohol cravings, including naltrexone, acamprosate, gabapentin, baclofen, and topiramate. You'll hear the practical “why” behind pairing meds, how we set expectations for naltrexone response, and how targeted dosing can give patients more control during high-risk moments. We also talk about monthly extended-release naltrexone (Vivitrol) and how we approach add-on oral dosing without overdoing it. Just as important, we keep coming back to the central clinical question: what does alcohol do for you? If drinking is driven by anxiety, insomnia, or trauma, the best AUD treatment may start with sleep, PTSD symptoms, nightmares, or triggers rather than another anti-craving pill. We close by zooming out to what best practice really looks like: therapy or groups, good sleep, nutrition, exercise, treatment of co-occurring mental health conditions, and more than one medication when it fits. Subscribe for more practical addiction medicine, share this with a clinician or friend who cares about recovery, and please leave a review so more people can find the show.To contact Dr. Grover: ammadeeasy@fastmailcom

Zafar Mirza is a Pakistani public health professional who served as the special assistant to the prime minister Imran Khan for Health from 2019 to 2020.The Pakistan Experience is an independently produced podcast looking to tell stories about Pakistan through conversations. Please consider supporting us on Patreon:https://www.patreon.com/thepakistanexperienceTo support the channel:Jazzcash/Easypaisa - 0325 -2982912Patreon.com/thepakistanexperienceAnd Please stay in touch:https://twitter.com/ThePakistanExp1https://www.facebook.com/thepakistanexperiencehttps://instagram.com/thepakistanexpeperienceThe podcast is hosted by comedian and writer, Shehzad Ghias Shaikh. Shehzad is a Fulbright scholar with a Masters in Theatre from Brooklyn College. He is also one of the foremost Stand-up comedians in Pakistan and frequently writes for numerous publications. Instagram.com/shehzadghiasshaikhFacebook.com/Shehzadghias/Twitter.com/shehzad89Join this channel to get access to perks:https://www.youtube.com/channel/UC44l9XMwecN5nSgIF2Dvivg/joinChapters:0:00 Introduction1:00 What happened at PIMS?4:20 Why it happened12:15 Neonatal Mortality in Pakistan18:06 Hepatitis C, Diabetes, HIV and Stunted Growth29:59 Healthcare System has collapsed37:30 Primary Health care and priorities of the Government49:00 Solutions and why Governments keep failing

Singapore declared war on diabetes a decade ago, yet the condition still affects around one in eleven adults, while rising obesity adds to concerns about Type 2 diabetes. Michelle Martin speaks with Dr Anuradha Negi, Senior Consultant Endocrinologist at the Aspen Diabetes & Endocrine Clinic, about what everyone should understand about Type 1 and Type 2 diabetes, who is most at risk, and the practical steps that can help prevent or better manage the condition. They also examine the growing role of continuous glucose monitoring (CGM). How much more can a sensor reveal compared with a finger-prick test? Who benefits most from having glucose readings throughout the day? And with CGM currently subsidised in Singapore for eligible patients with Type 1 and certain rarer forms of diabetes, could some people with Type 2 diabetes benefit from wider access? Plus, Dr Negi explains the limitations of CGM, when traditional glucose testing may still be necessary, and what good diabetes management looks like beyond medication.See omnystudio.com/listener for privacy information.

He Will Never Leave You  Life Of Joseph  Part 2  Genesis  Chapter 40

Jaume Segalés y los expertos de Mundo Natural hablan sobre la diabetes.

Sleep, Growth Hormone, and Autophagy: How Rest, Diet, and Fasting Support Metabolic Health and Longevity: Nutritionist Leyla Muedin discusses how deep, early non-REM sleep boosts growth hormone for muscle, bone, fat burning, and metabolic health, and reviews a Cell study in which UC Berkeley researchers mapped hypothalamic circuits and feedback through the locus coeruleus showing a tight balance between sleep, growth hormone release, and wakefulness, with implications for metabolic disease and neurodegeneration. She connects poor sleep to higher blood sugar, insulin, and cortisol, which can suppress growth hormone, and advises avoiding sweet post-workout foods (e.g., smoothies, bananas, fruit yogurt) that stimulate insulin and blunt growth hormone, recommending protein and fat instead. She then explains autophagy and mitophagy as cellular cleanup processes linked to longevity, noting autophagy peaks after 12 hours of fasting, highlighting roles in mitochondrial quality control, immunity, and neurodegenerative disease, and mentions interventions such as fasting, exercise, ketogenic diets, and investigational inducers like rapamycin and urolithin A.

Are we getting health, faith, money, and the future ALL WRONG?In this special compilation, Dr. Jamal Bryant and his guests take on some of the conversations most people are afraid to have.Can you truly be healthy without changing what you eat? Are Black fraternities and sororities really in conflict with Christianity? Has the church failed to answer the hard questions about Black identity? And could AI leave an entire generation behind?From Yahki Awakened and Rev. Dr. Skip Mason to Dr. John-Paul Foster and Pastor Justin Lester, nothing is off limits as they challenge what we've been taught about health, faith, the Black church, technology, purpose, and our future.Some of these opinions may challenge what you've always believed, but these are conversations we can't keep avoiding.*▶️ WATCH THE FULL EPISODES:*Pastor Justin Lester on TikTok, AI, and Why The Black Church Is Losing The Next Generation | S5 Ep.5https://youtu.be/7b6EEbz_6fYYahki Awakened on How Plant Diet Heals Fibroids, Diabetes, Autism & Reverses Disease | S5 Ep. 8https://youtu.be/N619JiRDCl0Rev. Dr. Skip Mason on The Black Church, HBCUs & Divine 9 Are Under Spiritual Attack? | S5 Ep. 9https://youtu.be/N619JiRDCl0Dr. John-Paul Foster BREAKS SILENCE on "Black Skin Idolatry", Fake Seminary Degrees & Church Silencehttps://youtu.be/pyOp9GmD_mcJamal Bryant Talks "Doctor" Credential Controversy, Reality of Black Homeownership and Mental Healthhttps://youtu.be/-oMlIGVELm0Jamal Bryant Calls Out Southern Baptist Church, Oprah Winfrey and YOU!!https://youtu.be/hsuP5B3EJcw*DISCLAIMER:* This podcast is presented for educational, informational, and entertainment purposes only. The views and opinions expressed by guests are their own and are not intended to serve as medical, psychological, therapeutic, or professional advice.Dr. Jamal Bryant and The Jamal Bryant Podcast: Let's Be Clear do not claim to be licensed medical professionals, therapists, or physicians, and this content should not be used as a substitute for guidance from qualified healthcare, mental health, legal, or professional experts.We encourage viewers to conduct their own research and consult licensed professionals regarding any medical or health-related concerns.~~~~~~The Jamal Bryant Podcast "Let's Be Clear" is a conversation that rips off the bandaid to serious relevant issues in the community and around the country. It assesses the wounds and offers prescriptions of insight, understanding and direction. No punches are pulled, but jabs are thrown to hit right between the eyes of every listener. New Episode Drops every Thursday at 12pm est. at jamalbryant.orgJoin our Membership or Support our Channel to get access to perks:https://www.youtube.com/channel/UC1yEY95beOqcUz5TUqxqVgQ/joinFollow or Subscribe on our socials ~https://www.facebook.com/jamalbryantpodcasthttps://www.instagram.com/jamalbryantpodcast/https://www.tiktok.com/@jamalbryantpodcast https://twitter.com/jamalbryantpod

In this episode, I opened this episode with a concept that I don't think gets talked about honestly enough — rage bolusing.It's what happens when your blood sugar won't come down, the frustration builds, and you just keep dumping insulin on top of insulin on top of insulin hoping something finally works. It feels like taking control. It isn't. It's one of the most emotionally driven and potentially dangerous patterns in Type 1 diabetes management — and almost all of us have been there at some point.Graham and I break down what rage bolusing actually is, why it happens, what typically triggers it, and most importantly — what to do instead. Because the answer isn't more insulin. The answer is a checklist, a process, and the ability to take a breath and work through what's actually going on instead of reacting from a place of frustration.From there the conversation takes an unexpected turn into surrender — not in a defeated way, but in the most powerful way. Why letting go of the emotional grip on your blood sugar numbers, your outcomes, and your frustration is one of the most transformative things you can do for your diabetes management and your mental health. And why if you can't get to that place of surrender, nothing else — not better insulin, not a new CGM, not a different protocol — is going to work the way you need it to.

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a series of recent breakthroughs and strategic moves that are shaping the future of drug development and patient care. Eli Lilly has achieved a significant milestone with the FDA's approval of Onswik, a once-weekly insulin therapy for type 2 diabetes. This innovative treatment is set to revolutionize diabetes management by offering a more convenient regimen, which could improve patient compliance and outcomes. Supported by robust phase 3 clinical trial data, Onswik is a testament to the importance of protein therapies in tackling metabolic diseases, highlighting Eli Lilly's commitment to advancing diabetes care. Additionally, Eli Lilly's collaboration with InnoCare Pharma exemplifies the trend of strategic partnerships playing an increasingly crucial role in accelerating drug discovery and development, focusing on five unmet medical targets with substantial financial milestones. In oncology, Elevar Therapeutics has received FDA approval for Lirafugratinib, a small molecule FGFR inhibitor targeting FGFR2-altered cholangiocarcinoma. This approval is a beacon of hope for patients with this challenging cancer type, emphasizing the potential of personalized medicine approaches in oncology. In another significant development, Elevar Therapeutics' FDA approval for Lyrfigtu marks a notable achievement as the first novel cancer drug from a Korean company to enter the U.S. market. This milestone underscores the global expansion of drug development capabilities and highlights Asian biopharmaceutical companies' growing influence. Promising clinical trial results continue to emerge. Merck's Remigromig demonstrated efficacy in a phase 2b/3 trial for diabetic macular edema as a Wnt pathway agonist, offering a novel approach in ophthalmology that could expand treatment options beyond VEGF pathways. In autoimmune diseases, Kyverna Therapeutics reported durable efficacy and safety for Mivocabtagene autoleucel in phase 3 trials for stiff person syndrome. This progress showcases the potential of CAR-T cell therapies in areas beyond oncology. Funding activities also highlight the sector's dynamism, with companies like Basecamp Research and BigHat Biosciences securing significant investments to advance AI-driven drug discovery platforms. These initiatives underscore the growing integration of artificial intelligence and machine learning in biopharmaceutical research—innovations that promise to expedite the identification and optimization of therapeutic candidates. On the regulatory front, Grail's Galleri multi-cancer blood test received positive recommendations from an FDA advisory committee. This liquid biopsy diagnostic holds promise for early cancer detection and screening advancements in precision medicine strategies in oncology. However, not all news is positive; Acadia Pharmaceuticals faced setbacks as its phase 2 trial for Remlifanserin missed primary endpoints in Alzheimer's disease psychosis, illustrating the challenges inherent in neurological drug development. Industry dynamics are further illustrated by Boehringer Ingelheim's strategic decision to offload its Shanghai CDMO to RAAS Blood Products, reflecting ongoing localization trends within pharmaceutical manufacturing. Meanwhile, AstraZeneca's Breztri received its third asthma-related approval from the European Commission, reinforcing its commitment to expanding its respiratory portfolio across key geographies. Additionally, legal actions such as the Florida Attorney General's lawsuit against three drug manufacturers and PBMs over alleged insulin price inflation highlight ongoing concerns about drug pricing. These actions may prompt further scrutiny and potential regulatory reforms within the pharmaceutical supply chain. Agentic AI is emerging as a pivotal trend in clinical trials, offering new models for connecting workflows and accelerating trial execution—a crucial advancement amid increasing trial complexity. Collectively, these developments illustrate an industry characterized by scientific innovation, strategic alliances, and regulatory achievements—all aimed at improving patient care and expanding access to novel therapies. As technological innovations like AI reshape clinical trials and companies navigate complex regulatory landscapes, the potential for breakthroughs in drug development remains high. These trends have profound implications for patient outcomes and the future direction of pharmaceutical research and development. Stay tuned as we continue to bring you more updates on these exciting advancements in our next episode.Support the show

Apryl is a 68-year-old grandmother of 9 who had issues with weight most of her life, which turned into Type 2 diabetes in the decades after her children were born. After being hospitalized with AFIB four years ago, she started doing research and came across the Dr. Ken Berry community and the Proper Human Diet. After adopting a PHD carnivore lifestyle in 2023, Apryl changed her relationship with food and totally reversed her Type 2 Diabetes, dropped over 40 lbs. and reversed heart disease as well as arthritis pain without medication. This inspired her to want to help other people do the same. Apryl studied with Primal Health Coach Institute and became a certified health coach at the end of 2024 and has supported several other people in navigating nutrition and lifestyle changes since then. Apryl's goal is to keep honing her skills as a Health Coach to help as many people as possible regain good metabolic health and continue to delve into the "real" science that supports that goal. Socials: YouTube: https://www.youtube.com/@AprylParcher Website: https://yourhealthcoachforlife.com Timestamps: 00:00 Trailer 00:35 Introduction 04:11 Dealing with health issues 07:16 Carnivore diet and intermittent fasting results 12:33 Experiencing food noise reduction 13:23 Struggling with food addiction 19:04 Living a healthy lifestyle 22:13 Challenges of switching to a new diet 26:38 Family's different diet choices 27:28 Explaining the ketogenic diet 32:19 Empowering people through interviews 34:13 Future interview predictions Join Revero now to regain your health: https://revero.com/YT Revero.com is an online medical clinic for treating chronic diseases with this root-cause approach of nutrition therapy. You can get access to medical providers, personalized nutrition therapy, biomarker tracking, lab testing, ongoing clinical care, and daily coaching. You will also learn everything you need with educational videos, hundreds of recipes, and articles to make this easy for you. Join the Revero team (medical providers, etc): https://revero.com/jobs ‪#Revero #ReveroHealth #shawnbaker  #Carnivorediet #MeatHeals #AnimalBased #ZeroCarb #DietCoach  #FatAdapted #Carnivore #sugarfree Disclaimer: The content on this channel is not medical advice. Please consult your healthcare provider.

Welcome to the latest episode (October 2026) of DOC Updates, where every month Neil Skolnik, MD and John Russell, MD review the most important articles on diabetes, obesity, and cardiometabolic disease. This month on DOC Updates: Zoungas et al; Atorvastatin, Cardiovascular Events, and Disability-free Survival in Older Adults. New England Journal of Medicine, 28 August 2026; doi.org/10.1056/NEJMoa2607314 Novartis announces Lp(a)HORIZON Phase III topline results for pelacarsen in patients with elevated Lp(a) and established cardiovascular disease (CVD), press release N. Kruger, et al; Tirzepatide and the risk of atherosclerotic cardiovascular events: population based cohort study. BMJ 2026; 394 doi.org/10.1136/bmj-2026-100011 Dufour, et al; Type 2 Diabetes and Longitudinal Changes in Cortical and Trabecular Bone Density, Microarchitecture, and Strength: The Framingham Study. Diabetes Care 2026; dc260846. doi.org/10.2337/dc26-0846 He, et al; Early Weight Loss in Impaired Glucose Tolerance Is Associated With Reduced Long-term Mortality and Cardiovascular Risk: The Da Qing Diabetes Prevention Outcome Study. Diabetes Care 2026; dc260689. doi.org/10.2337/dc26-0689 Leavens ELS, Pebley K, Smith TT, et al; Nicotine E-Cigarettes for Cigarette Smoking Cessation: Recommendations to US-Based Clinicians. JAMA. 2026;336(9):783–790. doi.org/10.1001/jama.2026.13087 Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health John J. Russell, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Chair-Department of Family Medicine, Abington Jefferson Health DOC Updates is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association's three science and medical journals—Diabetes, Diabetes Care, and Diabetes, Obesity, and CardioMetabolic CARE. Intended for practicing physicians and health care professionals, DOC Updates discusses how the latest research is relevant in clinical practice. For information about the American Diabetes Association's scholarly journals, visit diabetesjournals.org. For more about this podcast, click here.

He Will Never Leave You  Life Of Joseph  Part 1  Genesis  Chapter 39

Still the most commonly drug prescribed for people with diabetes (and the third most commonly prescribed drug in the US!) but what is it and what is it doing? Kelly and Erin talk through the very beginning of it's story to where we are now and everything in between. References:LaMoia TE, Shulman GI. Cellular and Molecular Mechanisms of Metformin Action. Endocr Rev. 2021;42(1):77-96. doi:10.1210/endrev/bnaa023American Diabetes Association Professional Practice Committee for Diabetes. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2026. Diabetes Care. 2026;49(Suppl 1):S183-S215. doi:10.2337/dc26-S009Pavlo Petakh, Kamyshna I, Kamyshnyi A. Effects of metformin on the gut microbiota: A systematic review. Mol Metab. 2023 Nov;77:101805. doi: 10.1016/j.molmet.2023.101805. Epub 2023 Sep 9. PMID: 37696355; PMCID: PMC10518565.Bu Y, Peng M, Tang X, et al. Protective effects of metformin in various cardiovascular diseases: Clinical evidence and AMPK-dependent mechanisms. J Cell Mol Med. 2022;26(19):4886-4903. doi:10.1111/jcmm.17519 LINKS:Email us your questions here: glucoseriotpod@gmail.comFind out more about Kelly at www.sixnutritionanddiabetes.comFind out more about Erin at www.erinphillipsnutrition.comDISCLAIMER: We are dietitians and diabetes educators but we are not YOUR dietitians and diabetes educators. The information provided in this podcast is not intended as individualized medical advice, nor is it a substitute for professional medical expertise or treatment. If you have a medical concern, go to your health care provider or seek other professional medical treatment.

Pam discusses the care and treatment of kids with diabetes with Dr. Asma Deeb, a leading pediatric endocrinologist in the Middle East and North Africa region who specializes in diabetes in children. Dr. Asma, who is the founder of the Arab Society for Pediatric Endocrinology and Diabetes (ASPED - @asped_news), shares her expertise and views on how far Type 1 Diabetes has come and what the future of diabetes looks like.   Join the Diapoint mailing list for exclusive insights, offers and diabetes wisdom. Visit the D-Shop where we offer beautiful, practical diabetes supplies and lifestyle accessories. The Ultimate T1D Game Plan: A game-changing home study program for parents of school-aged children with Type 1 Diabetes. Check out our Diabetes resources. Are you a healthcare provider or coach who wishes to coach your clients or have more meaningful conversations with your diabetes patients? Check out How to Coach People With Diabetes at www.diapointlearning.com Looking for health support? Set up a FREE Health Plan call today! Book a time to meet with Pam at this link. Watch our podcast episodes and more on our YouTube Channel! @DiapointTV Connect with Diapoint @diapointme: Instagram | Facebook | Twitter | Pinterest Connect with Diapoint Arabia: Instagram | Facebook | DiapointArabia.com Find episodes, show notes, and guest info for all Dia-Logue episodes on the Diapoint website. Would you like to sponsor our podcast? Get in touch: info@diapointme.com Diapoint is the place for people touched by diabetes. For more information and full details of our work, visit diapointme.com . Subscribe to the podcast so you get notifications for all our episodes, and please share it on social media or with anyone you think could benefit from this free content. Thank you for listening!

He Has Not Forgotten You  Part 3 Esther Chapter 6

Mit einem Bluttest lässt sich eine Vorstufe von Typ-1-Diabetes früh erkennen. Deswegen raten Fachleute jetzt, Kinder systematisch auf die Autoimmunkrankheit zu testen. Denn eine frühe Diagnose kann den Ausbruch hinauszögern und Kinder vor schweren Folgen schützen. Astrid Meisoll im Gespräch mit Prof. Anette-Gabriele Ziegler, Institut für Diabetesforschung beim Helmholtz-Zentrum München

¿Tener familiares con diabetes significa que también la desarrollarás? Descubre cómo tus hábitos y tu metabolismo pueden influir en el riesgo y qué cambios pueden ayudarte a cuidar la glucosa y proteger tu salud.

¿Comer sano se volvió un lujo o una moda inalcanzable? En este episodio nos metemos de lleno al jugoso (y polémico) mundo de la industria alimentaria. Nos acompaña Kim Nájera, Nutrióloga Clínica y Educadora en Diabetes, para desmentir los mitos más grandes de lo que comemos todos los días.Hablamos del polémico uso del Ozempic (GLP-1) para bajar de peso, por qué de pronto TODO tiene proteína (hasta el agua), el engaño detrás de los sellos de advertencia en el súper, y por qué un Pingüino a veces es la única cura para el estrés. Además, confesamos nuestros placeres culposos pop y por qué la comida de tu mamá siempre le va a ganar a un restaurante con estrella Michelin.¡Dale play y acompáñanos en la mesa!

There's more to Type 1 Diabetes than meets the eye.Blood sugars aren't just about food and insulin. Stress, hormones, movement, mindset, habits, and other unseen variables can all play a role.At T1D Mastery Live, we're going beyond the basics to help you understand YOUR diabetes, adapt your strategies, and raise your standards. San Diego Mission Bay ResortNovember 6–8, 2026Come learn, connect, and surround yourself with other T1Ds who are ready to keep pushing forward.Type 1 isn't our handcuffs—it's our fire.Grab your ticket and join us at T1D Mastery Live!https://t1dmasterylive.com>> ENJOY!Get the Free Diabetes Training: https://diabetesinaction.comoin Us for T1D Mastery Live in San Diego: https://t1dmasterylive.comJoin The Tribe: https://thewarriorstribe.comPurchase your copy of "The Blood Sugar Freedom Formula" book TODAY!https://www.amazon.com/dp/1964811880?psc=1&smid=ATVPDKIKX0DER&ref_=chk_typ_quicklook_imgToDpGrab your free ticket to this advanced T1D training here:https://diabetesinaction.comFree T1D Support Group Here: https://diabetesinaction.com/join-group-1---------Welcome to the Pardon My Pancreas podcast!! This show is all about REAL life with type 1 diabetes, understanding fluctuations, and how to stabilize your blood sugar for good. Your host is Matt Vande Vegte is a certified personal trainer, nutritionist, and type 1 diabetic whose biggest goal in life is to help people with diabetes around the world live their lives fearlessly. Looking for an online health coaching program to help you live your best life? Go to https://www.ftfwarrior.com to learn more about his program for diabetics only that is focused on helping you reach your goals while living a happier and healthier life. Join the Tribe today!This podcast is sponsored by FTF Warrior - An online health and fitness coaching company for type 1 diabetics dedicated to helping them master their blood sugars through any activity, exercise, or meal!https://www.ftfwarrior.comFollow Matt here:Instagram: https://www.instagram.com/ftfwarrior/Facebook: https://www.facebook.com/ftfwarrior/YouTube: https://www.youtube.com/c/ftfwarrior------------------------------------------------------Disclaimer: While we share our experiences with diabetes, nothing we discuss should be taken as medical advice. Please consult your doctor or medical professional for your health and diabetes management. 

In this episode, Graham and I get into something I find myself thinking about often - why is it so hard for people to eat well and live healthy lives? Not because they don't care. Not because they're lazy. But because the system is stacked against us. Ultra-processed foods are engineered to be addictive. Fast food is cheaper, faster, and more accessible than cooking a real meal after a ten-hour workday. And then the drive-through on the way home from that soccer tournament. This is how healthy choice becomes the hardest one.We also get honest about health insurance, why I only see my endocrinologist once or twice a year.

Bloc d'actualités. Le développement du traitement du diabete. Le château de Rusovce compte parmi les monuments historiques les plus remarquables de Bratislava.A propos des travaux de reconstruction. REPRISE

Dr. Chris Thompson, MD, Professor of Medicine at Harvard Medical School, Chief of Interventional Gastroenterology at Mass General Brigham in Boston, and Co-Director of the Center for Weight Management and Wellness, is a world-renowned expert on gastroenterology, metabolism, nutrition, and obesity medicine. He explains how your GI tract regulates hunger, fullness, and blood sugar, as well as the gut microbiome, metabolic health, and weight loss. We also discuss common GI tract issues and which particular tests or interventions are actually useful. We discuss both GLP-1 medications and non-GLP-1 approaches to weight loss. Given that gut health is vital to all the organs of the body, overall health, and longevity, our discussion ought to be of interest and practical value to everyone, including, of course, those struggling with gut health or weight loss challenges. Thank you to our sponsors AG1: https://drinkag1.com/huberman Function: https://functionhealth.com/huberman Lingo: https://hellolingo.com/huberman LMNT: https://drinklmnt.com/huberman Our Place: https://fromourplace.com/huberman Timestamps (00:00:00) Dr. Chris Thompson (00:02:16) Digestive Tract, Gut Hormones & Nutrient Absorption (00:08:06) Colon Microbiome & Colon Cancer Screening (00:11:13) Sponsors: LMNT & Lingo (00:13:40) Swallowing Problems & Zenker's Diverticula (00:16:08) Bowel Movements & Constipation (00:18:28) Fiber, Resistant Starch & the Gut Barrier (00:21:50) Intermittent Fasting & the Gut Microbiome (00:23:38) Fermented Foods, Microbial Diversity & Butyrate (00:27:12) H. pylori, Stress & Stomach Ulcers (00:30:20) GLP-1 Medications: Benefits & Limitations (00:33:42) Lower GLP-1 Doses, Weight Regain & Muscle Loss (00:37:35) GLP-1 Side Effects, Food Noise & Apathy (00:39:49) Bariatric Surgery & Medical Innovation (00:46:07) Sponsor: AG1 (00:47:44) Hunger & Satiety: Ghrelin, CCK, GIP & GLP-1 (00:50:01) Retatrutide & Combining Hormonal Targets (00:52:55) Ultra-Processed Foods, Overeating & Leptin (00:55:32) Incretin Discovery, Exendin-4 & the Gila Monster (00:59:35) Endoscopic Ultrasound & Pancreatic Biopsy (01:07:40) Early Metabolic Markers, CGMs & Fasting Insulin (01:13:06) Insulin Resistance & Metabolic Flexibility (01:15:53) Sponsor: Function (01:17:35) Patient Data, Screening & Treatment Adoption (01:26:31) AI, Robotics & Improving Procedures (01:29:27) Choosing a Surgeon & Measuring Procedure Quality (01:35:29) Image Guidance & Hyperspectral Imaging (01:37:19) Sponsor: Our Place (01:38:56) Diagnostics & Targeted Metabolic Treatments (01:42:45) Gastric Bypass, Foregut Exclusion & Diabetes (01:47:59) Duodenal Liners & Mucosal Resurfacing Research (01:52:58) Gut Permeability, Inflammation & Fatty Liver (01:59:39) Artificial Sweeteners, Fructose, Fats & Omega-3s (02:05:00) Resistance Training, Zone 2 Cardio & Intervals (02:06:31) Weight Set Point & Metabolic Adaptation (02:08:13) Endoscopic Sleeve Gastroplasty & Fundus Ablation (02:10:30) Magnetic Intestinal Connections & Combined Treatments (02:16:52) GLP-1 Gene Therapy Research (02:22:13) Innovation, Problem Solving & Teamwork (02:25:58) Zero-Cost Support, Sponsors & Neural Network Newsletter Disclaimer & Disclosures Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode of the SMFM Podcast, we continue our Diabetes Technology Series with a practical discussion on remote glucose monitoring in pregnancy. Dr. Heidi Leftwich is joined by Dr. Karin Fox and Dr. Amy Valent to explore how continuous glucose monitoring (CGM) and other remote monitoring tools are changing diabetes management in maternal-fetal medicine. The conversation covers how clinicians can use glucose trends to guide treatment decisions, identify patients who may benefit from closer remote follow-up, and use CGM data to support patient engagement and timely medication adjustments. The speakers also discuss strategies for managing large volumes of glucose data, setting expectations with patients, and developing effective team-based workflows. The episode then turns to the operational side of remote monitoring, including documentation, coding and billing considerations, integration into clinical workflows, and practical approaches for implementing remote glucose monitoring within an MFM practice. Resources:  https://events.medscapelive.org/website/93785/ Insulin Management for Gestational and Type 2 Diabetes in Pregnancy Application of continuous glucose monitoring and automated insulin delivery technologies for pregnant women with type 1, type 2, or gestational diabetes: an international consensus statement Continuous Glucose Monitoring for Diabetes Management During Pregnancy

He Has Not Forgotten you Part  2 Genesis Chapter 41

Brain Health Reset: 9 Weeks to Better Energy, Focus & Sleephttps://rawfoodmealplanner.kit.com/products/brain-health-reset-9-weeks-to-better-Join January 2027 RawFoodMealPlanner's 21-Day Challengehttps://rawfoodhealthempowermentsummit.com/the-rawfoodmealplanner-s-21-day-new-year-meal-prep-challenge Boost Your Wellness Journey:The Brain Reboot Plan: 5 Simple Daily Shifts for More Focus, Energy & Peacehttps://rawfoodmealplanner.com/brain-reboot-plan/Revitalize Your Brain: A Lifestyle Approach for Women Over 50https://rawfoodmealplanner.clickfunnels.com/webinar-replay-brain-health-breakthrough-coaching-programRESET: 3 Metabolic Mistakes Women 30+ Make And How to Fix Themhttps://rawfoodmealplanner.com/reset-3-metabolic-mistakes-women-30-make-and-how-to-fix-them/The Lancet published a study here https://www.thelancet.com/journals/lanhl/article/PIIS2666-7568(24)00191-0/fulltext emphasizing that young adults (ages 18–39) are a neglected but crucial window for dementia prevention. Most dementia research focuses on mid-to-late life, yet many modifiable risk factors that affect long-term brain health emerge or peak in young adulthood.Key Modifiable Risk FactorsEducation: Low levels reduce cognitive reserve and increase the risk of dementia.Hearing loss: One billion young adults globally are at risk due to unsafe listening practices.Traumatic brain injury (TBI): High rates from sports, motor accidents, and intimate partner violence.Hypertension: One in 12 young adults is affected; rates higher among Black Americans and in LMICs.Alcohol use: Peaks in early 20s, linked to long-term brain changes.Obesity & physical inactivity: Both rising rapidly; linked to inflammation and cardiovascular risk.Smoking/vaping: 90% of daily smokers start before 26.Depression & social isolation: Peak in early 20s, linked to later ADRD (Alzheimer's disease and related dementias) risk.Diabetes: 4% prevalence in young adults; prediabetes affects 1 in 4.Environmental factors: Air pollution, vision loss, high LDL cholesterol, and even emerging risks like sleep disruption, stress, spirituality, and microplastics.Join the Conversation:Subscribe and share this episode with anyone on their own path of health and transformation. // HOST Samantha Salmon, NBC-HWC Nationally Board Certified Health & Wellness Coach Brain Health Licensed Trainer | Integrative Nutrition Coach | Intuitive Nutrition Coach for Brain & Metabolic HealthThe information provided in this broadcast is for educational purposes only and is not intended as medical advice. These statements have not been evaluated by the Food and Drug Administration or the equivalent in your country. Any products/services mentioned are not intended to diagnose, treat, cure, or prevent disease. RawFoodMealPlanner.com © 2026

Join Dr. Martin in today's episode of The Doctor Is In Podcast.  

Welcome to the latest Midlife Minute. This episode unpacks ongoing research on Lp(a), explores how women's lipids change during the perimenopause-to-menopause transition, and clarifies what we can do about it. Stay tuned for more! IN THIS EPISODE, YOU WILL LEARN: How total cholesterol, LDL, and ApoB tend to rise most steeply around the final menstrual period, rather than increasing gradually with chronological aging Why women should have their Lp(a) checked both before and after menopause How oral and transdermal estradiol can affect LDL, HDL, triglycerides, and Lp(a) differently Why I recommend including ApoB when checking your lipids during the perimenopause window How your lifestyle can reduce your cardiovascular risk, even when your Lp(a) is elevated Why omega-3 fatty acids and commonly used lipid medications do not lower Lp(a) Why supplements are not replacements for statins in genuinely high-risk patients  I review the various PCSK9 inhibitors currently available, how they are administered, and their effects  How a CAC, a CT angiogram, and an AI-assisted CT angiogram can help women and their providers determine how aggressive their approach should be when Lp(a) is elevated Connect with Cynthia Thurlow   Follow on X, Instagram & LinkedIn Check out Cynthia's website. Submit your questions to support@cynthiathurlow.com  Join other like-minded women in a supportive, nurturing community: The Midlife Pause/Cynthia Thurlow.  Purchase Cynthia's book, The Menopause Gut. Cynthia's Intermittent Fasting Transformation Book The Midlife Pause Supplement Line References: 1. Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention: A Scientific Statement From the American Heart Association.Circulation. 2020. El Khoudary SR, Aggarwal B, Beckie TM, et al.Guideline 2. Menopause: A Cardiometabolic Transition. The Lancet. Diabetes & Endocrinology. 2022. Nappi RE, Chedraui P, Lambrinoudaki I, Simoncini T.Review 3. Dyslipidemia Across the Menopause Transition: Mechanisms, Trajectories, and Opportunities for Cardiovascular Prevention. Maturitas. 2026. Castaneda R, Tatit CP, Hurtado Andrade MD, Faubion SS, Shufelt CL.RecentReview 4. Lipoprotein(a) and Women's Cardiovascular Health: A Review. JACC. Advances. 2026. Michos ED, Saucier S, Mehran R, Koschinsky ML. 5. Lipid Metabolism in Women: A Review. Atherosclerosis. 2025. van Oortmerssen JAE, Mulder JWCM, Kavousi M, Roeters van Lennep JE.Review 6. Are Changes in Cardiovascular Disease Risk Factors in Midlife Women Due to Chronological Aging or to the Menopausal Transition?. Journal of the American College of Cardiology. 2009. Matthews KA, Crawford SL, Chae CU, et al.Observational 7. Trajectories of Lipids Around the Menopause Transition in Chinese Women: Results of the Kailuan Cohort Study. Fertility and Sterility. 2023. Dai Q, Wu S, Cao Z, et al. 8. Lipid Management in Patients With Endocrine Disorders: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology and Metabolism. 2020. Newman CB, Blaha MJ, Boord JB, et al.Guideline 9. The Effects of Menopause Hormone Therapy on Lipid Profile in Postmenopausal Women: A Systematic Review and Meta-Analysis. Frontiers in Pharmacology. 2022. Nie G, Yang X, Wang Y, et al.SR 10. Perspectives on Dyslipidemia and Coronary Heart Disease in Women. Journal of the American College of Cardiology. 2005. Bittner V.Review 11. Dyslipidemia in Midlife Women: Approach and Considerations During the Menopausal Transition. Maturitas. 2022. Torosyan N, Visrodia P, Torbati T, Minissian MB, Shufelt CL.Review 12. Effects of gender, age and menopausal status on serum apolipoprotein concentrations.13.Lipoprotein(a).The Journal of the American Medical Association. 2025. Mora S, Kronenberg     14. Why, how and in whom should we measure levels of lipoprotein(a): A review of the latest evidence and clinical implications. Diabetes, Obesity & Metabolism. 2025. Razavi AC, Bhatia HS, Blumenthal RS, Shapiro MD, Mehta A.RecentReview 15. Red Yeast Rice for Hypercholesterolemia: JACC Focus Seminar. Journal of the American College of Cardiology. 2021. Cicero AFG, Fogacci F, Zambon A.Review 16. Overall and Sex-Specific Effect of Berberine for the Treatment of Dyslipidemia in Adults: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials. Drugs. 2023. Blais JE, Huang X, Zhao JV.SR 17. Non-Genetic Influences on Lipoprotein(a) Concentrations. Atherosclerosis. 2022. Enkhmaa B, Berglund L.Review 18. NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis. Journal of the American College of Cardiology. 2018. Tsimikas S, Fazio S, Ferdinand KC, et al.Review 19. Consumption of a defined, plant‐based diet reduces lipoprotein(a), inflammation, and other atherogenic lipoproteins and particles within 4 weeks. Clinical Cardiology. 2018. Najjar RS, Moore CE, Montgomery BD. 20. Lipoprotein(a): Current Evidence for a Physiologic Role and the Effects of Nutraceutical Strategies. Clinical Therapeutics. 2019. Santos HO, Kones R, Rumana U, et al.Review 21. Effect of Lipid-Lowering Therapies on Lipoprotein(a) Levels: A Comprehensive Meta-Analysis of Randomized Controlled Trials. Atherosclerosis. 2025. Xie S, Galimberti F, Olmastroni E, et al.Recent 22. Effect of Omega-3 Fatty Acid Supplementation on the Postprandial Metabolism of Apolipoprotein(a) in Familial Hypercholesterolemia. Journal of Atherosclerosis and Thrombosis. 2023. Ying Q, Croyal M, Chan DC, et al.RCT 23.Lipoprotein(a) and Cardiovascular Disease. Lancet. 2024. Nordestgaard BG, Langsted A.Review 24. Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association. Arteriosclerosis, Thrombosis, and Vascular Biology. 2022. Reyes-Soffer G, Ginsberg HN, Berglund L, et al.Guideline 25.Clinical Trial Design for Lipoprotein(a)-Lowering Therapies: JACC Focus Seminar 2/3.Journal of the American College of Cardiology. 2023. Malick WA, Goonewardena SN, Koenig W, Rosenson RS.Review 26.2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American Collegeof Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2026. Writing Committee Members, Blumenthal RS, Morris PB, et al.Guideline 27. Noninvasive Coronary Atherosclerotic Plaque Imaging. JACC. Cardiovascular Imaging. 2023. Kwiecinski J, Tzolos E, Williams MC, et al.Review 28. Computed Tomography Angiography Versus Agatston Score for Diagnosis of Coronary Artery Disease in Patients With Stable Chest Pain: Individual Patient Data Meta-Analysis of the International COME-CCT Consortium. European Radiology. 2022. Wieske V, Walther M, Dubourg B, et al.SR 29. Association of Coronary Artery Calcium Score With Qualitatively and Quantitatively Assessed Adverse Plaque on Coronary CT Angiography in the SCOT-HEART Trial. European Heart Journal. Cardiovascular Imaging. 2022. Osborne-Grinter M, Kwiecinski J, Doris M, et al.Clinical Trial 30. AI-Guided Quantitative Plaque Staging Predicts Long-Term Cardiovascular Outcomes in Patients at Risk for Atherosclerotic CVD. JACC. Cardiovascular Imaging. 2024. Nurmohamed NS, Bom MJ, Jukema RA, et al.Observational 31. The Lancet Commission on Rethinking Coronary Artery Disease: Moving From Ischemia to Atheroma. Lancet. 2025. Zaman S, Wasfy JH, Kapil V, et al.Review 32. Efficacy and safety of novel lipoprotein(a)‐targeted therapies: A systematic review and meta‐analysis of randomized controlled trials. Diabetes, Obesity & Metabolism. 2026. Santana AUL, Yusufzai MO, Freitas APS, et al. Recent Opinion

Earlier this year, Eoin booked an Ironman on his birthday as a gift to himself.Now, with race day just around the corner, he breaks down what the last six months of preparation have actually looked like while managing Type 1 Diabetes.In this episode, Eoin talks through the physical training, managing his time around Ironman prep, nutrition, carb loading, and the adjustments he's made with insulin, ratios and his overall Diabetes management along the way.He also shares what the final week before the Ironman looks like, what he's learned throughout the process, and how he's preparing to get himself to the start line in the best position possible.This episode gives an insight into Eoin's personal experience of preparing for an Ironman while living with Type 1 Diabetes, and the lessons he's picked up along the way.As always, be sure to rate, comment, subscribe and share. Your interaction and feedback really helps the podcast. The more Diabetics that we reach, the bigger impact we can make!Questions & Stories for the Podcast?:theinsuleoinpodcast@gmail.comConnect, Learn & Work with Eoin:https://linktr.ee/insuleoin Hosted on Acast. See acast.com/privacy for more information.

On this episode of Diabetes Connections In the news… The ADA conference controversy continues with a boycott now, new patch pump approved, an update on long running research to reverse type 1, plus consensus guidelines on T1D screening, intermittent fasting for type 1, a new surprising study about COVID and T1D, statins, type 2 and dementia, and lots more..  This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider.  Want to let you know about a webinar I'm doing with Abbott later this month. That's Sept 23 at 7pm ET. We'll be talking about ketones, DKA and learn more about their dual CGM/ketone monitor that was just approved. Join us for a webinar September 23 Check out all of our events like Moms' Night Out and Club 1921 here. Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Transcript: On this episode of Diabetes Connections In the news… The ADA conference controversy continues with a boycott now, an update on long running research to reverse type 1, plus consensus guidelines on T1D screening, intermittent fasting for type 1, a new surprising study about COVID and T1D, statins, type 2 and dementia, and lots more.. It's all coming up right after this. (AD BREAK) Welcome! I'm your host Stacey Simms and this is an In The News episode.. where we bring you the top diabetes stories and headlines happening now. A reminder that you can find the sources and links and a transcript and more info for every story mentioned here in the show notes. We are off to Detroit this week for Moms' Night Out in Bloomfield Michigan. Super excited and as usual I'm getting last minute emails and DMs about respiration from people just finding out about the event. We will always figure it out so drop me a line. But please register now for Seattle next month! Tampa will be open soon as well! Want to let you know about a webinar I'm doing with Abbott later this month. That's Sept 23 at 7pm ET. We'll be talking about ketones, DKA and learn more about their dual CGM/ketone monitor that was just approved. Great crowd already registered for that, hope you can join us. The link is in the show notes. Okay.. our top story this week: XX Member of the American Diabetes Association… are now boycotting it. The notice of the boycott condemns leadership's actions after five researchers were removed by police from its annual meeting in June. Significantly, The editors of ADA's flagship journal, Diabetes Care, have joined on in support of the boycott. "Manuscripts submitted will not be handled until the boycott is over," said Steven Kahn, MBChB, the journal's editor in chief and one of the five researchers ejected from the meeting in New Orleans, in a LinkedIn post on Thursday. Kahn told MedPage Today that "the journal boycott is like establishing a picket line. The boycott already has hundreds of signatures of people who have pledged to suspend all ADA-related activities, including: Planning or attending any meetings led by ADA leadership or the board, including the 2027 ADA Scientific Sessions Participating in board-led activities regarding the investigation of the meeting's events, or the report generated by the "so-called 'independent' committee" Engaging in all other ADA operations, including presentations, fundraisers, grant reviews, manuscript reviews, journal management, manuscript submissions, and position statements The boycott will remain active until the ADA board of directors permits an independent formal review of the organization's structure and function to ensure it "properly represent[s] its professional membership." If demands are not met, signees plan to align with existing or newly formed medical societies. https://www.medpagetoday.com/endocrinology/diabetes/122977 https://docs.google.com/forms/d/e/1FAIpQLSd4h548X9qXgkVREQ71k2gDHiU8WFAFF78wTnmS20_ntwUM0w/viewform XX A new patch pump is coming to the US.. Beta Bionics, Inc. announces FDA clearance of Mint, the Company's patch pump featuring a transformative reusable and disposable architecture that does not require recharging, integrates with industry-leading continuous glucose monitors (CGM) and enables smartphone control for iOS and Android users. The Company expects to initiate the full commercial launch of Mint in the United States in the first quarter of 2027 Mint is expected to launch exclusively through the pharmacy channel. Also announced, that Eversense 365 is now compatible with Beta Bionics Senseonics expects development of the Eversense 365-iLet integration to be completed during the fourth quarter of 2026. Commercial launch is planned following completion of integration activities in the fourth quarter of 2026, subject to required testing, validation activities and applicable regulatory requirements. No word yet on timing for Eversense with Mint. https://www.manilatimes.net/2026/09/14/tmt-newswire/globenewswire/beta-bionics-announces-fda-clearance-of-mint-the-companys-transformative-patch-pump-and-unveils-3d-intelligence-as-its-next-generation-insulin-dosing-algorithm/2424457 XX Seven years after Johns Hopkins researchers discovered a previously unknown immune cell called the "X cell," they're now exploring whether that discovery could lead to a new treatment for type 1 diabetes. In preclinical studies, researchers developed an antibody that was able to target and eliminate specific immune cells responsible for attacking the pancreas's insulin-producing beta cells, while leaving the rest of the immune system intact. The researchers say the approach is especially promising because it could potentially reverse the autoimmune process soon after a type 1 diabetes diagnosis, rather than simply managing blood sugar. The work is still in the early stages and has not yet been tested in people; additional laboratory and preclinical studies are needed before human clinical trials can begin. sclerosis.https://hub.jhu.edu/2026/09/09/federal-funds-support-type-1-diabetes-treatment/ XX A new international consensus recommends routine screening for type 1 diabetes in the general population, offering the first framework for how healthcare providers could put widespread screening into practice. The guidance recommends screening children between ages 2 and 4, with children who test negative screened again at ages 6–8 and 10–15. Screening uses a blood test to look for islet autoantibodies, which can signal that the immune system is attacking insulin-producing cells years before symptoms appear or insulin is needed. Finding type 1 diabetes early can greatly reduce the risk of diabetic ketoacidosis, or DKA, at diagnosis and may give people access to treatments such as teplizumab that can delay progression to clinical T1D. https://www.prnewswire.com/news-releases/breakthrough-t1d-convened-paper-outlines-first-international-consensus-guidance-on-general-population-screening-for-early-stage-type-1-diabetes-302875788.html   XX Eating only between noon and 8 p.m. improved blood sugar control in a small study of adults with Type 1 diabetes and obesity, while avoiding an increase in serious complications. The promising findings offer the first evidence that time restricted eating could become another tool for managing the condition. For the study, Varady recruited adults with Type 1 diabetes who were also classified as obese After six months, the time-restricted eating group showed better blood sugar results than the calorie-reduction group. HbA1c, a blood test that reflects average blood sugar over the previous several months, fell by about 0.5% on average in the time-restricted group.   Couple of things here – very small study, only 32 people in total, who were then randomly placed in three groups with different styles of eating. Also, the lead researcher says this is the first study of it's kind for type 1 – which is obviously not true – you can do a quick google search or listen to past episodes of this show.. https://www.sciencedaily.com/releases/2026/09/260909231740.htm XX A large Danish study found that COVID-19 infection was associated with a slightly lower, rather than higher, risk of subsequently developing type 1 diabetes in people under age 30. Researchers studied more than 2,100 people diagnosed with T1D and found an overall 16% lower risk following a documented COVID infection, with the strongest association—a 42% reduction—seen 31 to 180 days after infection. The reduced risk appeared primarily among people who had not been vaccinated against COVID-19, although researchers cautioned that the vaccination findings were less certain. Importantly, this was an observational study, so it cannot show that COVID infection actually protects against type 1 diabetes or explain what caused the association. Researchers say the findings conflict with some earlier studies and should be investigated in other countries and populations. https://www.news-medical.net/news/20260908/COVID-19-linked-to-lower-subsequent-risk-of-type-1-diabetes.aspx   XX   Semaglutide, a medication widely used for type 2 diabetes and weight loss, may also provide an unexpected benefit for people with asthma. New research presented at the European Respiratory Society (ERS) Congress in Barcelona, Spain, found that semaglutide use was associated with a reduction in asthma attacks of nearly 40%.   The study was led by Professor Chloe Bloom, Clinical Associate Professor in Respiratory Epidemiology at the National Heart & Lung Institute, Imperial College London, UK, and presented by Dr. Bohee Lee.       Exploring GLP 1 Drugs and Lung Health   Dr. Bloom said: "GLP-1 receptor agonists are widely used to treat type 2 diabetes and obesity. Previous research suggests that they may have anti-inflammatory effects and may improve lung-related outcomes. However, asthma and COPD outcomes have not been included as outcomes in GLP-1 drug trials.   "We wanted to use real-world health records to investigate whether people with asthma or COPD who started GLP-1 receptor agonists had fewer acute respiratory attacks."   To investigate that question, the researchers analyzed electronic medical records from the UK. They carried out four parallel studies, each involving between 20,000 and 22,000 people who had started treatment with either a GLP-1 medication or a different type of diabetes drug known as a sulfonylurea.   The results suggested that people with airway diseases such as asthma and COPD who received GLP-1 therapies experienced fewer asthma attacks and COPD flare-ups than comparable patients who were prescribed other diabetes medications.   Semaglutide Showed the Strongest Effect   Among the GLP-1 drugs examined, semaglutide appeared to stand out, particularly for people with asthma.   Bloom explains: "The effect was strongest with semaglutide, especially in people with asthma, where use of semaglutide appears to be associated with nearly a 40% reduction in asthma attacks. Semaglutide also led to a 20% reduction in COPD flare-ups."   The findings suggest that people who already qualify for GLP-1 receptor agonists because they have obesity or type 2 diabetes could potentially receive an additional benefit for their respiratory health.   However, Bloom emphasized that the results are not enough to recommend these medications specifically as treatments for asthma or COPD.   She explains: "The findings from this study are encouraging, but they should not change treatment decisions on their own. People with asthma or COPD should not start GLP-1 receptor agonists specifically for their lung condition outside current prescribing guidance. While the findings suggest that some people taking GLP-1 receptor agonists may experience fewer respiratory attacks, this needs confirmation in clinical trials." https://www.sciencedaily.com/releases/2026/09/260909005155.htm XX XX A large study suggests women with endometriosis may have a higher risk of developing type 2 diabetes. Researchers analyzed health records from nearly 3 million women in Utah and found those diagnosed with endometriosis were 46% more likely to develop type 2 diabetes than those without the condition. The association was strongest among women who had not yet reached menopause and those without obesity, a group typically considered at lower risk for type 2 diabetes. Certain forms of endometriosis, including those found outside the pelvic area, were associated with more than twice the risk. Researchers say more study is needed, but the findings suggest endometriosis may have health effects beyond the reproductive system and could eventually help identify women who may benefit from earlier diabetes screening. https://www.nih.gov/news-events/nih-research-matters/endometriosis-may-increase-type-2-diabetes-risk   XX MiniMed files FDA submission for it's first patch pump, with a planned launch next summer. To be called MiniMed fit, it would have a 300-unit insulin reservoir and would accommodate up to seven days of wear time. MiniMed also completed enrollment of a pivotal trial for a fully closed loop algorithm, which would calculate the amount of insulin a person needs throughout the day, even if they don't announce meals or count carbohydrates. Interestingly, on an investor call, the CEO acknowledged that CGMs have been their – quote – Achilles' heel for a very long time" and that their newest sensor has helped drive insulin pump growth. https://www.medtechdive.com/news/minimed-submits-new-patch-pump-for-fda-clearance/829313/ XX A new study based on national health registers in Denmark suggests starting statin treatment after a type 2 diabetes diagnosis could lower the risk of dementia, and it seems that the sooner patients did, the better. The research, published in The Lancet Regional Health, is an observational study, meaning it can find statistically relevant patterns at the population level, but doesn't necessarily explain what caused those patterns. The results, however, were interesting enough that the researchers, led by medical doctor Tummas Ternhamar of the Copenhagen University Hospital, are urging doctors to consider statin therapy when diagnosing type 2 diabetes patients. "Statins seem to be underused in patients with type 2 diabetes, despite their protective effects against cardiovascular disease." https://www.sciencealert.com/statins-linked-to-lower-dementia-risk-in-massive-type-2-diabetes-study XX Big sports news with type 1. Alezander Zverev wins Family was at the heart of Alexander Zverev's U.S. Open triumph on Sunday as the German saluted the members of his inner circle and paid a heartfelt tribute to his mother for refusing to let diabetes define his future. The ​top seed beat American Ben Shelton 6-3 7-6(2) 5-7 6-2 at Flushing Meadows to finish a spectacular year at ‌the Grand Slams in which he proved his doubters wrong by going from perennial nearly man to two-time major champion. Shortly after his victory, Zverev reserved special praise for his mother Irina, a former professional tennis player, and credited her with ensuring type 1 diabetes never limited his ambitions in life. "When your 4-year-old son is diagnosed with diabetes and doctors in the office ​tell you that life and sports will be very limited for that child, it takes a very strong mother to ​say 'my son will be whatever he wants to be'," Zverev said. "'If he wants to be a tennis player, ⁠he'll be a tennis player. If he wants to do something else, he'll do something else, but this illness will not define us'. https://www.reuters.com/sports/tennis/zverev-hails-mothers-belief-after-us-open-triumph-2026-09-13/ XX Also, shout out to Garrett Mitchell (Center field  Milwaukee Brewers) lives with Type 1 Diabetes and hit a grand slam immediately after having a failed insulin pump site. He was diagnosed with T1D at the age of 9. And I have a T1d mom friend who's known him since he was a kid. Just great to see athletes talking about failed insulin sets like they're just part of everyday life.. because they are. Btw it was the first grand slam for the brewers all year. XX The new Netflix movie The Runner is getting a bit of a side eye from some in the diabetes community… the Gal Gadot thriller features a child with type 1 but as usual, there are some weird inaccuracies. Ginger Vieria from Diabetes nerd has a great vide on this – I'll link it up: but they're saying things like Insulin Dispenser instead of pump.. and some other weird stuff.. but I've heard such bad things about this movie I'm not sure it's worth watching just for this. Ginger's video is though! https://www.youtube.com/shorts/o8cw_gEZj5s  

How does documentation specificity affect diabetes code assignment? The details included in a medical record can significantly affect ICD-10-CM code assignments. Terry discusses several examples to show how documentation specificity, provider links between conditions, and medication use can influence diabetes coding. There are certain conditions for which a cause-and-effect relationship with diabetes can be assumed under coding guidelines; however, not every condition can automatically be considered related to diabetes. When a provider specifically links a condition to diabetes, that documentation can provide crucial support for accurate code assignment. Tune in today for some insights into the frequent, although challenging condition to code. Subscribe and Listen Find all of Terry’s official links in one place: https://www.terryfletcher.net/links The post ICD-10-CM Coding for Diabetes appeared first on Terry Fletcher Consulting, Inc..

(00:00:00) 233: Docs Answer Listener Questions: Global Edition III (00:00:11) Welcome to Itchy and Bitchy (00:00:42) Doc Itchy Medical Pet Supplements (00:01:05) Global Reach of Itchy and Bitchy (00:03:14) Addressing Listener Questions (00:06:26) Cyclospora and Food Safety (00:09:51) Tick-Borne Illnesses and Prevention (00:12:35) Break Announcement (00:12:53) Creatine Supplements: Benefits and Risks (00:15:51) Raw Diets and Food Safety for Pets (00:17:57) Break Announcement Listeners from around the globe send in questions for the Docs to give their best answers: most common countries for listenership, dog skin cancer, lumps and bumps, cardiac questions, diets and food science, cyclospora, toxins, vital monitoring and wearables, and more ....Become a supporter of this podcast: https://www.spreaker.com/podcast/itchy-and-bitchy-podcast--4303608/support.Itchy & Bitchy: Have you felt dismissed, misdiagnosed, or gaslit by a broken medical system.  From gut health, hormones, autoimmune disease, chronic pain, holistic health, and alternative medicine ... medical gaslighting, patient advocacy , or misdiagnosis we'll call that too.  For chronic illness warriors, self-advocacy seekers: WE OFFER  No BS